Table 1.
Study Title | ClinicalTrials.gov Identifier | Phase | Status | Enrollment |
---|---|---|---|---|
Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an “in Vivo” Evaluation of the Molecular Effects on β-catenin Signaling Pathway | NCT02077777 | II | Completed | 21 |
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (MesaCAPP) | NCT03070574 | II | Terminated | 8 |
Mesalazine Effects in Sporadic Colorectal Adenoma Patients | NCT01894685 | II | Completed | 74 |
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (MesaCAPP) | NCT04920149 | II | Recruiting | 260 |